Relay Therapeutics, Inc.

Q4 2020 13F Holders

Symbol
RLAY
CUSIP
75943R102
Type
Equity
Class
COM
Num filings
117
Total reported value, excl. options
$3.65 B
Manager Report Date Value ($000) Shares Option Type